Neuraxpharm Strengthens Global Footprint with Neuraxpharm Australia Launch
Neuraxpharm Group has launched Neuraxpharm Australia as part of its global expansion strategy, bringing key CNS treatments to the Australian market under the leadership of newly appointed Head of Commercial, Avendran Naidu.
Neuraxpharm Group | 23/07/2025 | By Mrinmoy Dey | 273
Neuraxpharm and Pharmathen to Co-Develop Long-Acting Injectable Therapies
Under this agreement, Neuraxpharm will have exclusive rights to commercialise these therapies in Europe, and in countries outside of Europe where the group has a direct presence, while Pharmathen will have exclusive rights for North America and all other countries not covered by Neuraxpharm.
Neuraxpharm Group | 23/12/2024 | By Aishwarya | 258
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy